tradingkey.logo

Caris Life Sciences Inc

CAI
30.514USD
-0.666-2.14%
交易中 美东报价延迟15分钟
8.58B总市值
亏损市盈率 TTM

Caris Life Sciences Inc

30.514
-0.666-2.14%

关于 Caris Life Sciences Inc 公司

Caris Life Sciences Inc. is a patient-centric, next-generation artificial intelligence tech bio company and precision medicine provider. The Company develops and commercializes solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale. Its entire portfolio of precision medicine solutions is designed to benefit patients, with an initial focus on oncology, and serves the clinical, academic, and biopharma markets. Its platform is purpose-built to leverage the convergence of next-generation sequencing (NGS), artificial intelligence (AI) and machine learning (ML) technologies, and high-performance computing. Its purpose-built, proprietary multi-omic profiling solutions capture and analyze molecular information from tissue and blood in a comprehensive manner. Its services for biopharma companies include prospective and retrospective profiling services, and companion diagnostics development.

Caris Life Sciences Inc简介

公司代码CAI
公司名称Caris Life Sciences Inc
上市日期Jun 18, 2025
CEOMr. David Dean Halbert
员工数量- -
证券类型Ordinary Share
年结日Jun 18
公司地址750 West John Carpenter Freeway
城市IRVING
上市交易所NASDAQ Global Select Consolidated
国家United States of America
邮编75039
电话18667718946
网址https://www.carislifesciences.com/
公司代码CAI
上市日期Jun 18, 2025
CEOMr. David Dean Halbert

Caris Life Sciences Inc公司高管

名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--
Dr. Lloyd B. Minor, M.D.
Dr. Lloyd B. Minor, M.D.
Independent Director
Independent Director
--
--
Mr. Peter M. Castleman
Mr. Peter M. Castleman
Lead Independent Director
Lead Independent Director
--
--
J. Russel Denton
J. Russel Denton
Senior Vice President, General Counsel, Secretary
Senior Vice President, General Counsel, Secretary
--
--
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Dr. Jeffrey L. (Jeff) Vacirca, M.D.
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Dr. George H. Poste, Ph.D.
Dr. George H. Poste, Ph.D.
Vice Chairman of the Board
Vice Chairman of the Board
511.70K
-2.76%
Mr. Luke Power
Mr. Luke Power
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
Chief Financial Officer, Senior Vice President, Chief Accounting Officer
99.57K
--
Mr. David (Dave) Fredrickson
Mr. David (Dave) Fredrickson
Independent Director
Independent Director
16.13K
--
Mr. Nathan Burns
Mr. Nathan Burns
Independent Director
Independent Director
--
--
Mr. Vijay Mohan
Mr. Vijay Mohan
Independent Director
Independent Director
--
--
Mr. Danny Phillips
Mr. Danny Phillips
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025Q2
暂无数据
地区USD
名称
营收
占比
United States
178.18M
98.22%
International
3.22M
1.78%
业务
地区
暂无数据

股东统计

更新时间: 8月19日 周二
更新时间: 8月19日 周二
持股股东
股东类型
持股股东
持股股东
占比
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
其他
33.18%
持股股东
持股股东
占比
Halbert (David D)
43.65%
Sixth Street Partners, LLC
8.67%
J.H. Whitney Capital Partners, LLC
7.20%
Castleman Peter M
3.69%
Coatue Management, L.L.C.
3.61%
其他
33.18%
股东类型
持股股东
占比
Individual Investor
48.41%
Investment Advisor
19.16%
Private Equity
10.55%
Hedge Fund
10.43%
Investment Advisor/Hedge Fund
5.41%
Pension Fund
0.56%
Sovereign Wealth Fund
0.13%
Research Firm
0.05%
其他
5.30%

机构持股

更新时间: 7月2日 周三
更新时间: 7月2日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
166
130.17M
46.29%
+128.70M
2025Q2
45
192.42M
69.23%
+189.87M
2025Q1
3
2.55M
0.92%
+2.55M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Halbert (David D)
122.76M
43.65%
-141.96K
-0.12%
Aug 11, 2025
Sixth Street Partners, LLC
24.39M
8.67%
+24.39M
--
Jun 30, 2025
J.H. Whitney Capital Partners, LLC
20.26M
7.2%
+20.26M
--
Jun 30, 2025
Castleman Peter M
10.37M
3.69%
+10.34M
+32049.87%
Jun 18, 2025
Coatue Management, L.L.C.
10.14M
3.61%
+10.14M
--
Jun 30, 2025
Fidelity Management & Research Company LLC
8.61M
3.06%
+8.61M
--
Jun 30, 2025
Braidwell LP
7.32M
2.6%
+7.32M
--
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
7.30M
2.6%
+7.30M
--
Jun 30, 2025
T. Rowe Price Associates, Inc.
6.76M
2.4%
+6.76M
--
Jun 30, 2025
Neuberger Berman, LLC
6.24M
2.22%
+6.24M
--
Jun 30, 2025
查看更多

持股ETF

更新时间: 11月2日 周日
更新时间: 11月2日 周日
机构名称
占比
ARK Genomic Revolution ETF
0.71%
Texas Capital Texas Small Cap Equity Index ETF
0.5%
Renaissance IPO ETF
0.49%
RiverNorth Patriot ETF
0.38%
Franklin Genomic Advancements ETF
0.16%
Invesco Russell 1000 Equal Weight ETF
0.08%
Texas Capital Texas Equity Index ETF
0.05%
T Rowe Price Small-Mid Cap ETF
0.05%
Fidelity Nasdaq Composite Index ETF
0.02%
iShares Global Equity Factor ETF
0.01%
查看更多
ARK Genomic Revolution ETF
占比0.71%
Texas Capital Texas Small Cap Equity Index ETF
占比0.5%
Renaissance IPO ETF
占比0.49%
RiverNorth Patriot ETF
占比0.38%
Franklin Genomic Advancements ETF
占比0.16%
Invesco Russell 1000 Equal Weight ETF
占比0.08%
Texas Capital Texas Equity Index ETF
占比0.05%
T Rowe Price Small-Mid Cap ETF
占比0.05%
Fidelity Nasdaq Composite Index ETF
占比0.02%
iShares Global Equity Factor ETF
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据
KeyAI